Stazi Filippo
UOC Cardiologia d'Urgenza, Ospedale San Giovanni Addolorata, Roma.
Eur Heart J Suppl. 2021 Oct 8;23(Suppl E):E156-E160. doi: 10.1093/eurheartj/suab111. eCollection 2021 Oct.
Leadless stimulation of the right ventricle is now a reality, especially in patients with very specific indications and clinical characteristics, even in the absence of randomized studies to support its use. The reduction of device costs and the refinement of atrioventricular synchronization algorithms will sanction its greater diffusion in the future. The possibility of using leadless technology also for resynchronization therapy, on the other hand, is currently a promising option but, pending randomized studies with robust case histories and adequate follow-ups, it should still be considered as a niche therapy, to be limited to centres highly specialized and in patients in whom conventional resynchronization has been impossible or ineffective.
右心室无导线起搏如今已成为现实，尤其适用于具有非常特定指征和临床特征的患者，即便缺乏随机研究来支持其应用。设备成本的降低以及房室同步算法的完善将促使其在未来得到更广泛的应用。另一方面，将无导线技术用于心脏再同步治疗目前是一个有前景的选择，但在有可靠病例记录和充分随访的随机研究完成之前，仍应将其视为一种小众治疗方法，仅限于高度专业化的中心，且适用于常规心脏再同步治疗无法实施或无效的患者。
